Contact information
Research groups
Colleges
Sofia Massa
PhD in Statistical Sciences (Padua)
OCTRU Lead Statistician
I am a Lead Statistician in the Oxford Clinical Trial Research Unit within the Centre for Statistics in Medicine.
Previously I was a Senior Statistician and Module Lead in Statistics in the Nuffield Department of Population Health within the Big Data Insitute. I co-lead the statistical and methodological aspects of research studies involving large population studies (UK Biobank, China Kadoorie Biobank, Cuba Prospective Study, Life Line Screening, TILDA among others).
Recent publications
-
Cost-effectiveness of regular surveillance versus endoscopy at need for patients with Barrett's esophagus: economic evaluation alongside the BOSS randomized controlled trial.
Journal article
Deidda M. et al, (2025), Gastroenterology
-
A review of the statistical analysis of randomised controlled trials conducted within OCTRU.
Journal article
Ooms A. et al, (2025), Trials, 26
-
Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): a randomized controlled trial.
Journal article
Old O. et al, (2025), Gastroenterology
-
Clinical outcomes from EMERALD trial: A phase I evaluating ultra-hypofractionated MR-Guided Adaptive SABR (SMART) for localized pancreatic cancer
Conference paper
Mukherjee S. et al, (2025), Radiotherapy and oncology, 206, S1783 - S1785
-
Five-year outcomes for patients sustaining severe fractures of the lower limb from the Wound Healing in Surgery for Trauma (WHIST) trial.
Journal article
Costa ML. et al, (2024), Bone joint j, 106-B, 858 - 864
-
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
Journal article
Watson M. et al, (2024), Therapeutic advances in musculoskeletal disease, 16
-
Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial.
Journal article
Hopewell S. et al, (2024), Bmj open, 14
-
Real-World Treat-to-Target Strategy in Psoriatic Arthritis: Baseline Characteristics from the MONITOR-PsA Cohort
Conference paper
James L. et al, (2024), Arthritis & rheumatology, 76, 2953 - 2956
-
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.
Journal article
Watson M. et al, (2024), Ther adv musculoskelet dis, 16
-
Cigarette smoking and risk of severe infectious respiratory diseases in UK adults: 12-year follow-up of UK biobank.
Journal article
McGeoch LJ. et al, (2023), J public health (oxf), 45, e621 - e629
-
Body Mass Index and Risk of Hospitalization or Death Due to Lower or Upper Respiratory Tract Infection.
Journal article
Bohrmann B. et al, (2023), Jama, 329, 1512 - 1514